Invention Grant
- Patent Title: Formulation of an antibody and use thereof
-
Application No.: US14773478Application Date: 2014-03-17
-
Publication No.: US11433029B2Publication Date: 2022-09-06
- Inventor: Markus Rast , Wolfgang Ise , Gerhard Becker , Peter Skufca , Henning Gieseler
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Nath, Goldberg & Meyer
- Agent Joshua B. Goldberg
- Priority: EP13159325 20130315
- International Application: PCT/EP2014/055279 WO 20140317
- International Announcement: WO2014/140361 WO 20140918
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K9/19 ; C07K16/28

Abstract:
The present invention provides a method for preparation of a lyophilized formulation of an anti-CD 20 antibody as well as to a lyophilized formulation of an anti-CD 20 antibody, comprising an anti-CD 20 antibody and having a residual moisture content in the range of 1% to 10%. The present invention also relates to the reconstituted formulation obtained by the method described herein, the use of said antibody formulation as a medicament, the use of the lyophilized formulation for the preparation of a medicament and a method of treating a patient.
Public/Granted literature
- US20160022585A1 FORMULATION OF AN ANTIBODY AND USE THEREOF Public/Granted day:2016-01-28
Information query